Showing results (261-270 of 400) with videos related to

Sort By:
Pageof 40
Bioorganic Chemistry|February 16, 2017
Novel N-hydroxybenzamides incorporating 2-oxoindoline with unexpected potent histone deacetylase inhibitory effects and antitumor cytotoxicityTran-Thi-Lan Huong, Do-Thi-Mai Dung, Nguyen-Van Huan, et al.
Biological & Pharmaceutical Bulletin|January 6, 2009
Low dose estrogen supplementation reduces mortality of mice in estrogen-dependent human tumor xenograft modelJong Soon Kang, Moo Rim Kang, Sang-Bae Han, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2011
Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agentsDao Thi Kim Oanh, Hoang Van Hai, Sang Ho Park, et al.
Theranostics|January 19, 2018
Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic miceYu Yeon Jung, Ki Cheon Kim, Mi Hee Park, et al.
Free Radical Biology & Medicine|December 25, 2016
Piperlongumine attenuates experimental autoimmune encephalomyelitis through inhibition of NF-kappaB activitySun Mi Gu, Jaesuk Yun, Dong Ju Son, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 26, 2013
New benzothiazole/thiazole-containing hydroxamic acids as potent histone deacetylase inhibitors and antitumor agentsTruong Thanh Tung, Dao Thi Kim Oanh, Phan Thi Phuong Dung, et al.
Chemistry & Biodiversity|April 19, 2018
Quinazoline-Based Hydroxamic Acids: Design, Synthesis, and Evaluation of Histone Deacetylase Inhibitory Effects and CytotoxicityDoan Thanh Hieu, Duong Tien Anh, Pham-The Hai, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 9, 2021
Aristolactam BIII, a naturally derived DYRK1A inhibitor, rescues Down syndrome-related phenotypesMiri Choi, Ae-Kyeong Kim, Youngwook Ham, et al.
Pageof 40